Medications that may lower your B12 levels Believe it or not, the medications you take for other conditions might be robbing you of your B12
Patent Expirations And Generic Competition Outlook One of the biggest factors influencing the long-term cost of GLP-1 medications is patent protection
Funding National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01 (NIH grant #R01DK119254) Pilot & Feasibility seed grant from the Stanford Diabetes Research Center (NIH grant #P30DK116074) Author contributions Conceptualization: AID, EAA Methodology: AID, CLM, LTN, EAA Investigation: AID, CLM, LTN, KL, ANP, IAH, SWB, CMK, CKJ, JY Visualization: AID, CLM, LTN Funding acquisition: EAA Project administration: EAA Supervision: EAA Writing original draft: AID, EAA Writing review & editing: CLM, LTN, KL, ANP, IAH, SWB, CMK, CKJ, JY, LH, DBS, HBR, EAA Competing interests E.A.A
But more serious rare risks are also possible, including pancreatitis and stomach or gallbladder problems
Patients now describe lives turned upside down by medical complications and the costs that follow, and are turning to our weight loss drug attorneys to hold manufacturers responsible through the legal system
